Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025

Rhea-AI Summary

Heron Therapeutics (HRTX) has announced it will host a conference call and live webcast on Tuesday, May 6, 2025, at 8:00 a.m. ET to discuss its first quarter 2025 financial results and recent business highlights.

Participants are encouraged to dial in fifteen minutes before the scheduled start time to avoid delays. The event will be accessible via phone through a registration link and webcast through the Investor Relations section of Heron's website. A recording will be available on the company's website for 60 days following the call.

CARY, N.C., April 22, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Tuesday, May 6, 2025, at 8:00 a.m. ET to report first quarter 2025 financial results and discuss recent business highlights.

The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com. An archive of the teleconference and webcast will also be made available on Heron's website for 60 days following the call.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.

Forward-looking Statements

This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.

Investor Relations and Media Contact:

Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
iduarte@herontx.com
858-251-4400

View original content to download multimedia:https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-first-quarter-2025-financial-results-on-tuesday-may-6-2025-302434958.html

SOURCE Heron Therapeutics, Inc.

FAQ

When will Heron Therapeutics (HRTX) report Q1 2025 earnings?

Heron Therapeutics will report Q1 2025 earnings on Tuesday, May 6, 2025, at 8:00 a.m. ET.

How can investors access Heron Therapeutics' Q1 2025 earnings call?

Investors can access the call via phone through a registration link or watch the webcast through the Investor Relations section of Heron's website at www.herontx.com.

How long will Heron Therapeutics' Q1 2025 earnings call recording be available?

The teleconference and webcast recording will be available on Heron's website for 60 days following the call.

What time should participants join HRTX's Q1 2025 earnings call?

Participants are encouraged to dial in fifteen minutes before the 8:00 a.m. ET scheduled start time to avoid delays.